Jpmorgan Chase & CO View Ray, Inc. Transaction History

Jpmorgan Chase & CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.35 - $3.28 $1,778 - $16,662	5,080 Added 4.32%	122,601 $42,000
Q1 2023 May 18, 2023	BUY	$3.28 - $4.81 $372,014 - $545,545	113,419 Added 2764.97%	117,521 $406,000
Q1 2023 May 11, 2023	SELL	$3.28 - $4.81 $1.14 Million - $1.68 Million	-348,490 Reduced 98.84%	4,102 $14,000
Q4 2022 Feb 13, 2023	SELL	$3.65 - $4.82 $451,183 - $595,809	-123,612 Reduced 25.96%	352,592 $1.58 Million
Q3 2022 Nov 14, 2022	SELL	$2.66 - $3.97 $1.28 Million - $1.91 Million	-480,529 Reduced 50.23%	476,204 $1.73 Million
Q2 2022 Aug 11, 2022	SELL	$2.42 - $4.05 $32,667 - $54,670	-13,499 Reduced 1.39%	956,733 $2.54 Million
Q1 2022 May 11, 2022	BUY	$3.45 - $5.83 $3.16 Million - $5.34 Million	915,731 Added 1680.21%	970,232 $3.8 Million
Q4 2021 Feb 10, 2022	BUY	$4.89 - $7.59 $12,254 - $19,020	2,506 Added 4.82%	54,501 $300,000
Q3 2021 Nov 12, 2021	BUY	$5.18 - $7.41 $269,334 - $385,282	51,995 New	51,995 $375,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.